{"id":"https://openalex.org/W2946106947","doi":"https://doi.org/10.1159/000500487","title":"Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial","display_name":"Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2946106947","doi":"https://doi.org/10.1159/000500487","mag":"2946106947","pmid":"https://pubmed.ncbi.nlm.nih.gov/31117088","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6878752"},"language":"en","primary_location":{"id":"doi:10.1159/000500487","doi":"https://doi.org/10.1159/000500487","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000500487","pdf_url":null,"source":{"id":"https://openalex.org/S4393917655","display_name":"The Nephron journals/Nephron journals","issn_l":"1660-8151","issn":["1660-8151","2235-3186"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephron","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1159/000500487","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071555943","display_name":"Tadao Akizawa","orcid":"https://orcid.org/0000-0002-6150-9201","observed_orcids":["https://orcid.org/0000-0002-6150-9201"]},"institutions":[{"id":"https://openalex.org/I119182057","display_name":"SHOWA Medical University","ror":"https://ror.org/04mzk4q39","country_code":"JP","type":"education","lineage":["https://openalex.org/I119182057"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tadao Akizawa","raw_affiliation_strings":["Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, akizawa@med.showa-u.ac.jp","Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, akizawa@med.showa-u.ac.jp","institution_ids":["https://openalex.org/I119182057"]},{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I119182057"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036113498","display_name":"Masaomi Nangaku","orcid":"https://orcid.org/0000-0001-7401-2934","observed_orcids":["https://orcid.org/0000-0001-7401-2934"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaomi Nangaku","raw_affiliation_strings":["Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0001-7401-2934","affiliations":[{"raw_affiliation_string":"Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071947905","display_name":"Takuhiro Yamaguchi","orcid":"https://orcid.org/0000-0002-7961-9417","observed_orcids":["https://orcid.org/0000-0002-7961-9417"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuhiro Yamaguchi","raw_affiliation_strings":["Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan","institution_ids":["https://openalex.org/I201537933"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masanobu Arai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masanobu Arai","raw_affiliation_strings":["Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038230275","display_name":"Ryosuke Koretomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryosuke Koretomo","raw_affiliation_strings":["Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109402763","display_name":"Kazuo Maeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuo Maeda","raw_affiliation_strings":["Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089024212","display_name":"Yuya Miyazawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108598","display_name":"Japan Tobacco (Japan)","ror":"https://ror.org/01xdq1k91","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210108598"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuya Miyazawa","raw_affiliation_strings":["Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Division, Japan Tobacco Inc., Tokyo, Japan","institution_ids":["https://openalex.org/I4210108598"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113820739","display_name":"Hideki Hirakata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257655","display_name":"Fukuoka Renal Clinic","ror":"https://ror.org/05hf5kp66","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405257655"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Hirakata","raw_affiliation_strings":["Fukuoka Renal Clinic, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fukuoka Renal Clinic, Fukuoka, Japan","institution_ids":["https://openalex.org/I4405257655"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8435,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.96829646,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"143","issue":"2","first_page":"77","last_page":"85"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor","display_name":"hypoxia-inducible factor prolyl hydroxylase inhibitor","score":0.9200000166893005},{"id":"https://openalex.org/keywords/anemia-of-chronic-kidney-disease","display_name":"anemia of chronic kidney disease","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/hemoglobin-maintenance","display_name":"hemoglobin maintenance","score":0.7059999704360962},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.7929999828338623},{"id":"https://openalex.org/keywords/hepcidin","display_name":"hepcidin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/ferritin","display_name":"ferritin","score":0.9480000138282776},{"id":"https://openalex.org/keywords/total-iron-binding-capacity","display_name":"total iron binding capacity","score":0.871999979019165},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9125733375549316},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.777350664138794},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.7148654460906982},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.6763214468955994},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6723438501358032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6164795160293579},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5882434248924255},{"id":"https://openalex.org/C2778319317","wikidata":"https://www.wikidata.org/wiki/Q22327449","display_name":"Ferritin","level":2,"score":0.5091206431388855},{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.49003517627716064},{"id":"https://openalex.org/C2778917026","wikidata":"https://www.wikidata.org/wiki/Q43041","display_name":"Hemoglobin","level":2,"score":0.48818522691726685},{"id":"https://openalex.org/C2776768029","wikidata":"https://www.wikidata.org/wiki/Q14882371","display_name":"Hepcidin","level":3,"score":0.4832492470741272},{"id":"https://openalex.org/C2781404941","wikidata":"https://www.wikidata.org/wiki/Q2178381","display_name":"Darbepoetin alfa","level":3,"score":0.4681912660598755},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4528126120567322},{"id":"https://openalex.org/C153852466","wikidata":"https://www.wikidata.org/wiki/Q907072","display_name":"Transferrin saturation","level":4,"score":0.4515187442302704},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42541220784187317},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32680708169937134},{"id":"https://openalex.org/C2777417653","wikidata":"https://www.wikidata.org/wiki/Q1313081","display_name":"Iron deficiency","level":3,"score":0.24557390809059143},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07778275012969971},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005293","descriptor_name":"Ferritins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006435","descriptor_name":"Renal Dialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D034442","descriptor_name":"N-substituted Glycines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D064451","descriptor_name":"Hepcidins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D064799","descriptor_name":"Hypoxia-Inducible Factor-Proline Dioxygenases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1159/000500487","doi":"https://doi.org/10.1159/000500487","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000500487","pdf_url":null,"source":{"id":"https://openalex.org/S4393917655","display_name":"The Nephron journals/Nephron journals","issn_l":"1660-8151","issn":["1660-8151","2235-3186"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephron","raw_type":"journal-article"},{"id":"pmid:31117088","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31117088","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephron","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:6878752","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6878752/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephron Clin Pract","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1159/000500487","doi":"https://doi.org/10.1159/000500487","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000500487","pdf_url":null,"source":{"id":"https://openalex.org/S4393917655","display_name":"The Nephron journals/Nephron journals","issn_l":"1660-8151","issn":["1660-8151","2235-3186"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nephron","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1571358690","https://openalex.org/W1972566766","https://openalex.org/W1974141178","https://openalex.org/W1988403143","https://openalex.org/W1995817487","https://openalex.org/W1999889125","https://openalex.org/W2006046265","https://openalex.org/W2007553857","https://openalex.org/W2018814956","https://openalex.org/W2030334534","https://openalex.org/W2033803279","https://openalex.org/W2045159867","https://openalex.org/W2061356986","https://openalex.org/W2076674466","https://openalex.org/W2095421717","https://openalex.org/W2103517401","https://openalex.org/W2105642896","https://openalex.org/W2111337780","https://openalex.org/W2112234535","https://openalex.org/W2116991069","https://openalex.org/W2120939456","https://openalex.org/W2121128671","https://openalex.org/W2126707535","https://openalex.org/W2132857214","https://openalex.org/W2135454486","https://openalex.org/W2152233370","https://openalex.org/W2152494980","https://openalex.org/W2158623958","https://openalex.org/W2257941018","https://openalex.org/W2272875085","https://openalex.org/W2331665138","https://openalex.org/W2562262017","https://openalex.org/W2580449060","https://openalex.org/W2584947097","https://openalex.org/W2622043747","https://openalex.org/W2738794292","https://openalex.org/W2800908159","https://openalex.org/W2885003119","https://openalex.org/W3149132779"],"related_works":["https://openalex.org/W2914891827","https://openalex.org/W3208950730","https://openalex.org/W3160338797","https://openalex.org/W7135017388","https://openalex.org/W4214668932","https://openalex.org/W4407863273","https://openalex.org/W4294556237","https://openalex.org/W4323347567","https://openalex.org/W3192679673","https://openalex.org/W3188553437"],"abstract_inverted_index":{"BACKGROUND:":[0],"Enarodustat":[1,175,191],"(JTZ-951)":[2],"is":[3],"an":[4,61],"orally":[5],"available":[6],"hypoxia-inducible":[7],"factor":[8],"prolyl":[9],"hydroxylase":[10],"inhibitor":[11],"that":[12],"increases":[13],"endogenous":[14],"erythropoietin":[15],"levels":[16,154,196],"in":[17,47,81,98,117,125,197],"the":[18,37,99,131,141,145,156,160],"treatment":[19,94,148],"of":[20,33,60,73,101,133,147,162,167,206],"anemia":[21],"associated":[22],"with":[23,51,95,122,200],"chronic":[24],"kidney":[25],"disease":[26],"(CKD).":[27],"OBJECTIVE:":[28],"A":[29],"phase":[30],"2b":[31],"study":[32],"enarodustat":[34,69,123,207],"to":[35,66,104],"assess":[36],"hemoglobin":[38],"(Hb)":[39],"response,":[40],"safety,":[41],"and":[42,178,185,193],"maintenance":[43],"dosage":[44],"was":[45,149,186],"conducted":[46],"Japanese":[48],"anemic":[49,198],"patients":[50,199],"hemodialysis-dependent":[52,201],"CKD.":[53,202],"METHODS:":[54],"Subjects":[55],"receiving":[56],"a":[57,71,82,108],"stable":[58],"dose":[59,72,124,171],"erythropoiesis-stimulating":[62],"agent":[63],"were":[64],"randomized":[65],"receive":[67],"once-daily":[68],"at":[70,144],"2,":[74,130,164],"4,":[75],"or":[76,79,173],"6":[77,86],"mg":[78,103],"placebo":[80],"double-blind":[83],"manner":[84],"for":[85],"weeks":[87],"(Period":[88],"1)":[89],"followed":[90],"by":[91],"24-week":[92],"open":[93],"enarodustat,":[96],"adjusted":[97],"range":[100,110,143,158],"2-8":[102],"maintain":[105,152],"Hb":[106,118,138,153,195],"within":[107,140,155],"target":[109,142,157],"(10.0-12.0":[111],"g/dL;":[112],"Period":[113,126,129,163],"2).":[114],"RESULTS:":[115],"Change":[116],"from":[119],"baseline":[120],"increased":[121,181],"1.":[127],"In":[128],"proportion":[132],"subjects":[134,168],"who":[135],"maintained":[136,194],"their":[137],"level":[139],"end":[146],"65.1%.":[150],"To":[151],"over":[159],"course":[161],"approximately":[165],"80%":[166],"required":[169],"2":[170],"adjustments":[172],"fewer.":[174],"decreased":[176],"hepcidin":[177],"ferritin":[179],"levels,":[180],"total":[182],"iron-binding":[183],"capacity,":[184],"generally":[187],"well":[188],"tolerated.":[189],"CONCLUSIONS:":[190],"corrected":[192],"Phase":[203],"3":[204],"studies":[205],"are":[208],"currently":[209],"ongoing.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-05-29T00:00:00"}